Litcius/Paper detail

Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study

Maxim Grymonprez, Andreas Capiau, Stéphane Steurbaut, Koen Boussery, Els Mehuys, Annemie Somers, Mirko Petrović, Tine L. De Backer, Lies Lahousse

2023Cardiovascular Drugs and Therapy14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineVitamin K antagonistPharmacodynamicsConcomitantAtrial fibrillationHazard ratioAspirinDrugPharmacologyConfidence intervalWarfarinPharmacokineticsAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesIntracerebral and Subarachnoid Hemorrhage Research
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study | Litcius